These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30216942)

  • 1. Targeted Gene Panel Sequencing for Molecular Diagnosis of Kallmann Syndrome and Normosmic Idiopathic Hypogonadotropic Hypogonadism.
    Kim JH; Seo GH; Kim GH; Huh J; Hwang IT; Jang JH; Yoo HW; Choi JH
    Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):538-544. PubMed ID: 30216942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Characteristics of Novel FGFR1 Mutations in Patients with Isolated Gonadotropin-Releasing Hormone Deficiency.
    Choi JH; Oh A; Lee Y; Kim GH; Yoo HW
    Exp Clin Endocrinol Diabetes; 2021 Jun; 129(6):457-463. PubMed ID: 32485746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of pathogenic variants and digenic disease in patients diagnosed with normosmic hypogonadotropic hypogonadism/Kallmann Syndrome.
    Poch A; Dougherty MP; Roman RA; Chorich L; Hawkins Z; Kim SH; Kim HG; Layman LC
    Mol Cell Endocrinol; 2024 Aug; 589():112224. PubMed ID: 38593951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes.
    Gach A; Pinkier I; Szarras-Czapnik M; Sakowicz A; Jakubowski L
    Reprod Biol Endocrinol; 2020 Jan; 18(1):8. PubMed ID: 31996231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.
    Stamou MI; Georgopoulos NA
    Metabolism; 2018 Sep; 86():124-134. PubMed ID: 29108899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next generation sequencing approach identifies eighteen new candidate genes in normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Bosley ME; Duckworth CG; Porter KR; Kim SH; Kim HG; Chorich LP; Sullivan ME; Choi JH; Cameron RS; Layman LC
    Mol Cell Endocrinol; 2016 Dec; 437():86-96. PubMed ID: 27502037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
    Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency.
    Balasubramanian R; Choi JH; Francescatto L; Willer J; Horton ER; Asimacopoulos EP; Stankovic KM; Plummer L; Buck CL; Quinton R; Nebesio TD; Mericq V; Merino PM; Meyer BF; Monies D; Gusella JF; Al Tassan N; Katsanis N; Crowley WF
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17953-8. PubMed ID: 25472840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism.
    Aoyama K; Mizuno H; Tanaka T; Togawa T; Negishi Y; Ohashi K; Hori I; Izawa M; Hamajima T; Saitoh S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1111-1118. PubMed ID: 28915117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience.
    Shin SJ; Sul Y; Kim JH; Cho JH; Kim GH; Kim JH; Choi JH; Yoo HW
    Ann Pediatr Endocrinol Metab; 2015 Mar; 20(1):27-33. PubMed ID: 25883924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
    Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
    Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, hormonal, and genetic characteristics of 25 Chinese patients with idiopathic hypogonadotropic hypogonadism.
    Liu Q; Yin X; Li P
    BMC Endocr Disord; 2022 Jan; 22(1):30. PubMed ID: 35090434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
    Jongmans MC; van Ravenswaaij-Arts CM; Pitteloud N; Ogata T; Sato N; Claahsen-van der Grinten HL; van der Donk K; Seminara S; Bergman JE; Brunner HG; Crowley WF; Hoefsloot LH
    Clin Genet; 2009 Jan; 75(1):65-71. PubMed ID: 19021638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of gene variants in a cohort of hypogonadotropic hypogonadism: Diagnostic utility of custom NGS panel and WES in unravelling genetic complexity of the disease.
    Gach A; Pinkier I; Sałacińska K; Szarras-Czapnik M; Salachna D; Kucińska A; Rybak-Krzyszkowska M; Sakowicz A
    Mol Cell Endocrinol; 2020 Nov; 517():110968. PubMed ID: 32763379
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.